Clinical trial
Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
NCT02570750 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Non-interventional Study Of The Effect Of Smoking Status Of The Patient On The Success Of Etanercept Therapy In Psoriasis
- Lead sponsor
- Pfizer
- Phase
- Observational
- Overall status
- Completed
- Start date
- May 7, 2015
- Completion date
- December 5, 2016
- Enrollment
- 183 (actual)
- Sites
- 30
Conditions
As the registry lists them; a condition with its own page is linked.
chronic plaque psoriasis